Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid
Recruiting now · Not applicable
Conditions studied: Cholangiocarcinoma, Colorectal Cancer, Multiple Myeloma
In brief
The overall goal of the randomized control trial (RCT) will be to evaluate the efficacy of modifications to a web-based tool for patient decision-making regarding return of genomic results that will more closely focus on rare cancers. Participants will be given access to a web-based decision aid (or a standard control) that guides participants in making decisions about what type of genomic results they would like to receive from testing performed in the PE-CGS study (NCT06340646).
Key facts
- Study ID
- NCT06910670
- Run by
- Washington University School of Medicine
- People needed
- 240
- Starts
- 2025-04-03
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-07-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Washington University School of Medicine — St Louis, Missouri, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.